Q3 2021 Gossamer Bio Inc Earnings Call Transcript
Good day, and thank you for standing by. Welcome to the Gossamer Bio Q3 Earnings Call. (Operator Instructions)
I would now like to hand the conference over to your speaker today, Mr. Bryan Giraudo. Financial and Chief Operating Officer. Thank you. Please go ahead.
Thank you, operator, and thank you all for joining us this afternoon. I am joined on today's call by Gossamer Bio's Chairmen, Co-Founder, Chief Executive Officer, Faheem Hasnain; Laura Carter, Gossamer Bio's Chief Scientific Officer; and Richard Aranda, Gossamer Bio's Chief Medical Officer.
Earlier this afternoon, Gossamer Bio issued a press release announcing its financial results for the third quarter ended September 30, 2021, in addition to providing a corporate update. Please note that certain information discussed on this call today is covered under the safe harbor provision of the Private Securities Litigation Reform Act. We caution listeners that during this call, Gossamer management will be making forward-looking statements.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |